Herbert Rudolf Neuman MD

Internal Medicine•Redwood City, CA

Physician

Join to View Full Profile

858 Corriente Point DrRedwood City, CA 94065
Phone+1 650-620-9711

Education & Training

Ascension St Vincent Hospital IndianapolisResidency, Internal Medicine, 1992 - 1995
Southern Illinois University School of MedicineClass of 1992

Certifications & Licensure

CA State Medical License 2013 - 2026
IL State Medical License 2003 - 2014
FL State Medical License 1998 - 2005

Clinical Trials

Evaluation of Nephrogenic Systemic Fibrosis (NSF) in Patients With Chronic Kidney Disease Following OptiMARK Injection Start of enrollment: 2009 Feb 01
Withdrawn
Fed Study of Chlorpheniramine Polistirex and Hydrocodone Polistirex Capsules and Tussionex® Pennkinetic® Extended Release Oral Suspension Start of enrollment: 2003 Sep 01
Completed
Phase 1
Fasting Study of Oxycodone Hydrochloride 30 mg Tablets and Roxicodone™ 30 mg Tablets Start of enrollment: 2003 Jan 01
Completed
Phase 1
Fed Study of Controlled-Release Oxycodone Hydrochloride 40 mg Tablets and OxyContin® 40 mg Tablets Start of enrollment: 2005 Apr 01
Completed
Phase 1
Fasting Study of Chlorpheniramine Polistirex and Hydrocodone Polistirex Capsules and Tussionex® Pennkinetic® Extended Release Oral Suspension Start of enrollment: 2003 Sep 01
Completed
Phase 1
Fasting Study of Oxycodone Hydrochloride 15 mg Tablets and Roxicodone™ 15 mg Tablets Start of enrollment: 2003 Feb 01
Completed
Phase 1
Fasting Study of Hydromorphone Hydrochloride 8 mg Tablets and Dilaudid 8 mg Tablets Start of enrollment: 2002 Dec 01
Completed
Phase 1
Fed Study of Oxycodone Hydrochloride 30 mg Tablets and Roxicodone™ 30 mg Tablets Start of enrollment: 2003 Feb 01
Completed
Phase 1
Fasting Study of Controlled-Release Oxycodone Hydrochloride 40 mg Tablets and OxyContin® 40 mg Tablets Start of enrollment: 2005 Apr 01
Completed
Phase 1
Study to Evaluate the Effect of Age (Geriatric) and Kidney Function on the Safety, Efficacy and Pharmacokinetics of OctreoScan in Patients Who Have New or Recurrent Tumors Start of enrollment: 2003 Jul 01
Terminated
Phase 4
Bioequivalence of a Test Troche Formulation of Fentanyl Citrate (400 mcg) Compared to Actiq® 400 mcg, Cephalon, Inc. Start of enrollment: 2006 Aug 01
Completed
Phase 1
Join now to see all

Press Mentions

Isosceles Pharmaceuticals Appoints Herbert Neuman, MD, MBA Chief Medical Officer and Adds Thomas Harrison, LH.D as a Strategic AdvisorSeptember 14th, 2021